Variations in analysts’ EPS estimates for Larimar Therapeutics Inc. (LRMR)

In the latest session, Larimar Therapeutics Inc. (NASDAQ: LRMR) closed at $3.65 up 0.97% from its previous closing price of $3.62. In other words, the price has increased by $+0.0350 from its previous closing price. On the day, 618007 shares were traded. LRMR stock price reached its highest trading level at $3.7000 during the session, while it also had its lowest trading level at $3.4450.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.



For a deeper understanding of Larimar Therapeutics Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 14.20 and its Current Ratio is at 14.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 17 when Celano Michael bought 5,000 shares for $3.73 per share. The transaction valued at 18,632 led to the insider holds 112,746 shares of the business.

BEN-MAIMON CAROLE bought 5,000 shares of LRMR for $18,525 on May 17. The President and CEO now owns 266,829 shares after completing the transaction at $3.71 per share. On May 17, another insider, Truitt Joseph, who serves as the Director of the company, bought 2,750 shares for $3.73 each. As a result, the insider paid 10,258 and bolstered with 2,750 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 158.37M and an Enterprise Value of 45.35M.

Stock Price History:

Over the past 52 weeks, LRMR has reached a high of $6.85, while it has fallen to a 52-week low of $1.53. The 50-Day Moving Average of the stock is 4.5259, while the 200-Day Moving Average is calculated to be 4.0747.

Shares Statistics:

For the past three months, LRMR has traded an average of 265.11K shares per day and 629.5k over the past ten days. A total of 43.90M shares are outstanding, with a floating share count of 39.71M. Insiders hold about 7.80% of the company’s shares, while institutions hold 90.90% stake in the company. Shares short for LRMR as of May 14, 2023 were 223.84k with a Short Ratio of 0.26M, compared to 303.72k on Apr 13, 2023. Therefore, it implies a Short% of Shares Outstanding of 0.52% and a Short% of Float of 0.88%.

Earnings Estimates

There are 5 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.19 for the current quarter, with a high estimate of -$0.15 and a low estimate of -$0.27, while EPS last year was -$0.47. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.16 and low estimates of -$0.32.

Analysts are recommending an EPS of between -$0.64 and -$1.16 for the fiscal current year, implying an average EPS of -$0.83. EPS for the following year is -$1.06, with 4 analysts recommending between -$0.79 and -$1.52.